Oxatomide

Oxatomide
Clinical data
Trade names	Tinset, others
Other names	KW-4354; McN-JR 35443; R-35443
AHFS/Drugs.com	International Drug Names
Routes of; administration	By mouth
ATC code	R06AE06 (WHO) ;
Legal status
Legal status	In general: ℞ (Prescription only);
Identifiers
	IUPAC name 1-{3-[4-(diphenylmethyl)piperazin-1-yl]propyl}-1,3-dihydro-2H-benzimidazol-2-one;
CAS Number	60607-34-3 ;
PubChem CID	4615;
ChemSpider	4454 ;
UNII	J31IL9Z2EE;
KEGG	D01773 ;
ChEMBL	ChEMBL13828 ;
CompTox Dashboard (EPA)	DTXSID4045181 ;
ECHA InfoCard	100.056.637
Chemical and physical data
Formula	C27H30N4O
Molar mass	426.564 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C2Nc1ccccc1N2CCCN5CCN(C(c3ccccc3)c4ccccc4)CC5;
	InChI InChI=1S/C27H30N4O/c32-27-28-24-14-7-8-15-25(24)31(27)17-9-16-29-18-20-30(21-19-29)26(22-10-3-1-4-11-22)23-12-5-2-6-13-23/h1-8,10-15,26H,9,16-21H2,(H,28,32) ; Key:BAINIUMDFURPJM-UHFFFAOYSA-N ;
	(verify)

Oxatomide, sold under the brand name Tinset among others, is a first-generation antihistamine of the diphenylmethylpiperazine family which is marketed in Europe, Japan, and a number of other countries.^[1]^[2]^[3]^[4] It was discovered at Janssen Pharmaceutica in 1975.^[5] Oxatomide lacks any anticholinergic effects.^[2] In addition to its H₁ receptor antagonism, it also possesses antiserotonergic activity similarly to hydroxyzine.^[2]

It was patented in 1976 and came into medical use in 1981.^[6]

Chemistry

Synthesis

Oxatomide synthesis:^[7]

Reaction of 2-Benzimidazolinone with isopropenyl acetate leads to the singly protected imidazolone derivative (2). Alkylation of this with 3-chloro-1-bromopropane affords the functionalized derivative (3). Alkylation of the monobenzhydryl derivative of piperazine (4) with 3 gives oxatomide (5), after hydrolytic removal of the protecting group.

References

^ J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 912–. ISBN 978-1-4757-2085-3.
^ ^a ^b ^c Ohmori K, Ishii H, Nito M, Shuto K, Nakamizo N (May 1983). "[Pharmacological studies on oxatomide (KW-4354). (7) Antagonistic effects on chemical mediators]". Nippon Yakurigaku Zasshi. Folia Pharmacologica Japonica (in Japanese). 81 (5): 399–409. doi:10.1254/fpj.81.399. PMID 6138301.
^ Index Nominum 2000: International Drug Directory. Taylor & Francis. 2000. pp. 768–. ISBN 978-3-88763-075-1.
^ "Oxatomide".
^ Harry Schwartz (August 1989). Breakthrough: the discovery of modern medicines at Janssen. Skyline Pub. Group. p. 149. ISBN 978-1-56019-100-1.
^ Fischer, Jnos; Ganellin, C. Robin (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 548. ISBN 9783527607495.
^ J. Vandenberk et al., DE 2714437; eidem, U.S. Patent 4,250,176 (1977, 1981 both to Janssen).

[Elks2014-1] J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 912–. ISBN 978-1-4757-2085-3.

[pmid6138301-2] Ohmori K, Ishii H, Nito M, Shuto K, Nakamizo N (May 1983). "[Pharmacological studies on oxatomide (KW-4354). (7) Antagonistic effects on chemical mediators]". Nippon Yakurigaku Zasshi. Folia Pharmacologica Japonica (in Japanese). 81 (5): 399–409. doi:10.1254/fpj.81.399. PMID 6138301.

[IndexNominum2000-3] Index Nominum 2000: International Drug Directory. Taylor & Francis. 2000. pp. 768–. ISBN 978-3-88763-075-1.

[Drugs.com-4] "Oxatomide".

[Schwartz1989-5] Harry Schwartz (August 1989). Breakthrough: the discovery of modern medicines at Janssen. Skyline Pub. Group. p. 149. ISBN 978-1-56019-100-1.

[Fis2006-6] Fischer, Jnos; Ganellin, C. Robin (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 548. ISBN 9783527607495.

[7] J. Vandenberk et al., DE 2714437; eidem, U.S. Patent 4,250,176 (1977, 1981 both to Janssen).

[1]

[2]

[3]

[4]

[5]

[6]

[7]